We are live on
!
Find out more
ITP
Iron Triangle Partners Portfolio holdings
AUM
$875M
1-Year Est. Return
49.85%
This Fund
S&P 500
This Quarter
Est. Return
+8.58%
1 Year Est. Return
+49.85%
3 Year Est. Return
+151.9%
5 Year Est. Return
+239.84%
10 Year Est. Return
–
AUM
$971M
AUM Growth
+$184M
(+23%)
Cap. Flow
+$141M
Cap. Flow
% of AUM
14.52%
Top 10 Holdings %
Top 10 Hldgs %
59.64%
Holding
36
New
9
Increased
10
Reduced
6
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$79.3M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$65.2M |
| 3 |
Waters Corp
WAT
|
+$53.8M |
| 4 |
Intuitive Surgical
ISRG
|
+$46.3M |
| 5 |
Guardant Health
GH
|
+$33.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$59.5M |
| 2 |
Labcorp
LH
|
+$43.4M |
| 3 |
Haemonetics
HAE
|
+$36.6M |
| 4 |
Surgery Partners
SGRY
|
+$32.1M |
| 5 |
Zimmer Biomet
ZBH
|
+$25.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 98.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLK
26
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $861K | 0.09% |
+25,000
| New | +$858K |
|
|
EXAS
27
DELISTED
Exact Sciences
EXAS
| – | – |
-100,000
| Closed | -$13.2M |
|
|
28
Haemonetics
HAE
$3.63B
| – | – |
-330,000
| Closed | -$36.6M |
|
29
IQVIA
IQV
$35.6B
| – | – |
-100,000
| Closed | -$19.3M |
|
|
30
Labcorp
LH
$24.7B
| – | – |
-197,880
| Closed | -$43.4M |
|
31
Natera
NTRA
$37B
| – | – |
-150,000
| Closed | -$15.2M |
|
32
Outset Medical
OM
$80.1M
| – | – |
-6,667
| Closed | -$5.44M |
|
33
Royalty Pharma
RPRX
$26B
| – | – |
-100,000
| Closed | -$4.36M |
|
|
34
Surgery Partners
SGRY
$1.98B
| – | – |
-725,000
| Closed | -$32.1M |
|
|
35
UnitedHealth
UNH
$379B
| – | – |
-160,000
| Closed | -$59.5M |
|
36
Vericel Corp
VCEL
$2.31B
| – | – |
-160,000
| Closed | -$8.89M |
|
Similar funds
8KM
MFG
NP
GGI
WFAL
OBWP
TWM
AGC
Iron Triangle Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Iron Triangle Partners held 36 positions worth $971M, up 23% from $786M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Iron Triangle Partners deployed $141M of net new capital in Q2 2021, opening 9 new positions and adding to 10 existing holdings. Its largest new stake was Humana: 181,512 shares worth $80.4M.
By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $25.8M trimmed.
- Iron Triangle Partners's largest Q2 2021 buy was Humana: 181,512 shares worth $80.4M.
- Iron Triangle Partners added most to Guardant Health in Q2 2021, an estimated $33.6M increase.
- Iron Triangle Partners's biggest Q2 2021 reduction was Zimmer Biomet, cutting an estimated $25.8M.
- Iron Triangle Partners fully exited UnitedHealth in Q2 2021, selling an estimated $59.5M.
- Iron Triangle Partners's ten largest holdings make up 60% of its $971M portfolio in Q2 2021.
- Iron Triangle Partners opened 9 new positions and closed 10 in Q2 2021.
- Iron Triangle Partners's portfolio value rose 23% quarter-over-quarter to $971M.
Based on Iron Triangle Partners's 13F filing for Q2 2021, filed 16 Aug 2021.